Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.575 USD | +0.19% | +4.06% | +10.56% |
05-09 | Transcript : Mersana Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (MRSN) MERSANA THERAPEUTICS Posts Q1 Revenue $9.2M, vs. Street Est of $8.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.56% | 314M | |
+7.92% | 113B | |
+10.39% | 106B | |
+0.41% | 22.27B | |
-12.03% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.92% | 17.24B | |
+7.15% | 14.29B | |
+36.68% | 12.52B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Citigroup Upgrades Mersana Therapeutics to Buy From Neutral, Raises Price Target to $5 From $1